Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy | Science
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Alzheimer’s disease (AD) is the leading cause of dementia and is characterized by progressive amyloid accumulation followed by tau-mediated neurodegeneration. Despite progress in anti-amyloid immunotherapies, important limitations remain, highlighting…
